Targeted Microperimetry Grids for Focal Lesions in Intermediate AMD: PINNACLE Study Report 7

Targeted grids improved the detection and understanding of how focal retinal changes affect visual function in patients with iAMD, supporting the development of therapeutic interventions.

Authors

Institutions

Publication Details

Journal
Investigative Ophthalmology & Visual Science
Published
2025-02-04
DOI
https://doi.org/10.1167/iovs.66.2.6
Citations
5
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
8.54

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Targeted Microperimetry Grids for Focal Lesions in Intermediate AMD: PINNACLE Study Report 7

Martin J. Menten, Lars G. Fritsche, Daniel Rueckert, Maximilian Pfau et al.
5 citations
Investigative Ophthalmology & Visual Science
Retinal Diseases and Treatments
8.54
article

Targeted Microperimetry Grids for Focal Lesions in Intermediate AMD: PINNACLE Study Report 7

Martin J. Menten, Lars G. Fritsche, Daniel Rueckert, Maximilian Pfau, Stefan Futterknecht, Sophie Riedl, Julia Mai, Hendrik P. N. Scholl, Sobha Sivaprasad, Kristina Pfau, Philipp Anders, Andrew Lotery, A Toby Prevost, Chrysoula Gabrani, Hrvoje Bogunović, Ursula Schmidt-Erfurth, Ursula Hall
article en
5 citations

Abstract

Targeted grids improved the detection and understanding of how focal retinal changes affect visual function in patients with iAMD, supporting the development of therapeutic interventions.

Investigative Ophthalmology & Visual ScienceVol. 66(2)
Moorfields Eye Hospital NHS Foundation Trust (GB), Austrian Research Institute for Artificial Intelligence (AT), King's College London (GB), University of Michigan (US), University Hospital of Basel (CH), Michigan United (US), Vista Klinik (CH), Institute of Molecular and Clinical Ophthalmology Basel (CH), University of Southampton (GB), University College London (GB), Imperial College London (GB), Medical University of Vienna (AT)
National Science Foundation, Amgen, Sanofi, Biogen, BrightFocus Foundation, Alnylam Pharmaceuticals, Wellcome Trust, Apellis Pharmaceuticals, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Novo Nordisk, Heidelberg Engineering, Genentech, Allergan, Janssen Pharmaceuticals, Daiichi Sankyo Europe
Openalex Percentile: Top 3%
Retinal Diseases and Treatments
8.54
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.